Jump to content
RemedySpot.com

CD19 monoclonal from India

Rate this topic


Guest guest

Recommended Posts

Guest guest

Another CD19 monoclonal has been announced by Glenmark

Pharmaceuticals of Switzerland/India called GBR 401.

The company plans to move forward with development and

clinical trials.

This follows XmAb5574 (Xencor Inc) with has been studied by

JC Byrd et al for the past year or more.

Very early days...

~chris

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...